Skip to main content

Advertisement

Log in

Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To compare the effect of 4 day course (study group) with 7 day course (control group) of antibiotic treatment in neonatal pneumonia, on treatment success rate.

Methods

This randomized controlled trial was conducted in a tertiary teaching hospital. Seventy, term and near-term neonates with pneumonia who had clinical remission by 48 h of antibiotic therapy were included. The neonates were randomized to receive a total of 4 d of antibiotics (Group 1) or 7 d of antibiotics (Group 2). The outcome measure was treatment failure in each group within 3 d of discharge.

Results

The treatment success rate of both the groups was 100%. There was a significant reduction in the duration of hospital stay (p < 0.001), antibiotic usage (p < 0.001), and cost (p < 0.001) in the 4 d group. On follow up till 28 d of enrollment, no infective morbidity was found in either group.

Conclusions

For term and near-term neonates who become clinically asymptomatic within 48 h of antibiotic therapy, 4 d of antibiotic therapy is as effective and safe as 7 d of antibiotic therapy, with significant reduction in hospital stay, antibiotic usage and cost.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bang AT, Bang RA, Morankar VP, Sontakke PG, Solanki JM. Pneumonia in neonates: can it be managed in the community? Arch Dis Child. 1993;68:550–6.

    Article  CAS  Google Scholar 

  2. Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed. 2005;90:211–9.

    Article  Google Scholar 

  3. Morrins AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis. 2014;6:101–12.

    Article  Google Scholar 

  4. Wise R, Hart T, Cars O, et al. Antimicrobial resistance. Is a major threat to public health. BMJ. 1998;317:609–10.

    Article  CAS  Google Scholar 

  5. Remington JS, Klein JO. Bacterial infections of the respiratory tract: pneumonia. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and the newborn infant. 7th ed. New York: Elsevier; 2011. p. 285–92.

    Google Scholar 

  6. Engle WD, Jackson GL, Sendelbach D, et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near term infants. Am J Perinatol. 2000;20:421–6.

    Article  CAS  Google Scholar 

  7. Zhong B. How to calculate sample size in randomised controlled trial? J Thorac Dis. 2009;1:51–4.

    PubMed  PubMed Central  Google Scholar 

  8. Hengst JM. The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care. 2003;3:1–13.

    Article  Google Scholar 

  9. Chiesa C, Panero A, Rossi N, Stegagno M, Giusti MD, Osborn JF. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26:664–72.

    Article  CAS  Google Scholar 

  10. Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010;97:165–74.

    Article  Google Scholar 

  11. Mathur NB, Garg K, Kumar S. Respiratory distress in neonates with special reference to pneumonia. Indian Pediatr. 2002;39:529–37.

    CAS  PubMed  Google Scholar 

  12. Sivanandan S, Soriasham AS, Swarnam K. Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr. 2011;2011: 712150:9.

    Article  Google Scholar 

  13. Cotton CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotising enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58–66.

    Article  Google Scholar 

  14. Cotton CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr; National Institute for Child Health and Human Development Neonatal Research Network. The association of third generation cephalosporin use and invasive candidiasis in extremely low birth weight infants. Pediatrics. 2006;118:717–22.

    Article  Google Scholar 

  15. Saini SS, Dutta S, Ray P, Narang A. Short course versus 7-day course of intravenous antibiotics for probable neonatal septicaemia: a pilot, open label, randomized control trial. Indian Pediatr. 2011;48:19–24.

    Article  Google Scholar 

  16. Chowdhary G, Dutta S, Narang A. Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis. J Trop Pediatr. 2006;52:427–32.

    Article  CAS  Google Scholar 

  17. Gathwala G, Sindani A, Singh J, Choudhry O, Chaudhary U. Ten days vs 14 days antibiotic therapy in culture proven neonatal sepsis. J Trop Pediatr. 2010;56:433–5.

    Article  Google Scholar 

  18. Pasha YZ, Ahmadpour-Kacho M, Behmadi R, Jahangir T. 3-day versus 5-day course of intravenous antibiotics for suspected early onset neonatal sepsis: a randomized controlled trial. Iran J Pediatr. 2014;24:673–8.

    PubMed  PubMed Central  Google Scholar 

  19. Mathur NB, Kharod P, Kumar S. Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized controlled trial. J Trop Pediatr. 2015;61:119–25.

    Article  CAS  Google Scholar 

  20. Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34:263–73.

    Article  CAS  Google Scholar 

  21. Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr. 1997;86:209–12.

    Article  CAS  Google Scholar 

  22. Delèvaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62:337–40.

    Article  Google Scholar 

  23. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174:84–92.

    Article  CAS  Google Scholar 

Download references

Contributions

NBM conceptualized and designed the study, finalized the manuscript and is guarantor of the paper. AM was involved in acquisition of data and drafted the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. B. Mathur.

Ethics declarations

Conflict of Interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mathur, N.B., Murugesan, A. Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial. Indian J Pediatr 85, 963–967 (2018). https://doi.org/10.1007/s12098-018-2708-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-018-2708-y

Keywords

Navigation